Jennifer A.'s Company Details
San Carlos, CA, US • 250 - 499 Employees
BioTech/Drugs
ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer, primarily focused on orphan and rare diseases. We are dedicated to our patients and committed to delivering medications that meet unmet needs in the current therapeutic landscape.
Biopharmaceutical
oral therapies
autoimmune diseases
inflammatory disorders
orphan and rare diseases
pancreatic cancer
diabetic nephropathy
ANCA-associated vasculitis
atypical hemolytic uremic syndrome
chemokine and chemoattractant receptors
Focal Segmental Glomerulosclerosis
oral therapeutics
immuno-oncology
Hidradenitis Suppurativa
Chronic Kidney Disease
Diabetic Nephropathy
Pancreatic Cancer
C3 Glomerulopathy
Small Molecule Therapeutics
Chemoattractant System
Chemokine
Drug Discovery
Inflammatory Bowel Disease (IBD)
Rheumatoid Arthritis (RA)
Avacopan
Complement Receptor
ADVOCATE
AURORA
LUMINA
B2B
Biotech
SaaS
Commercial Physical Research
Biotechnology
Biotech Pharmaceuticals